4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-002402
Executive VP, CFO & COO bought 500 shares at an average $3.28 ($1,638)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Marvin Donald Executive VP, CFO & COO | 2022-03-16 | Purchase | +250 | $3.30 | $825 | 1,750 | D |
| Marvin Donald Executive VP, CFO & COO | 2022-03-16 | Purchase | +250 | $3.25 | $813 | 2,000 | D |
| Derivatives | |||||||
| Marvin Donald Executive VP, CFO & COO | 2021-11-08 | Grant or award · Option to Purchase American Depositary Shares | +196,875 | 196,875 | D | ||
| Open-market purchases · 500 sh · avg $3.28 · $1,638 | |||||||
Loading xslF345X03/ownership.xml…